Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease
NCT02953405 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2016-11-02
Summary
Prescription and Persistence of Antithrombotic agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients with MCA(Middle Cerebral Artery) Disease.
Conditions
- MCA - Middle Cerebral Artery Dissection
Interventions
- DRUG
-
Clopidogrel
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2018-11-30
- Completion
- 2018-11-30
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke
NCT01790997 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Oral Anticoagulants in Stroke Patients
NCT02353585 ·Status: COMPLETED
-
Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke
NCT02828540 ·Status: COMPLETED ·Phase: PHASE2
-
Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE(PATH-STROKE)
NCT06269432 ·Status: RECRUITING ·Phase: PHASE4
-
Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke
NCT03552354 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke
NCT01273935 ·Status: COMPLETED
-
Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke
NCT01955642 ·Status: COMPLETED
-
Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke
NCT00821821 ·Status: COMPLETED ·Phase: PHASE2
-
Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
NCT03661411 ·Status: COMPLETED ·Phase: PHASE4
-
Intensive Drug Therapy for Ischemic Stroke
NCT05620615 ·Status: UNKNOWN
-
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
NCT02549846 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
NCT00840671 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Anti-platelet in Treatment of Acute Ischemic Stroke
NCT03266731 ·Status: UNKNOWN ·Phase: NA
-
A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
NCT03766581 ·Status: COMPLETED ·Phase: PHASE2
-
Antiplatelet Therapy for AIS Patients With Thrombocytopenia
NCT06053021 ·Status: RECRUITING ·Phase: NA
-
Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke
NCT04142151 ·Status: UNKNOWN ·Phase: NA
-
Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial
NCT07111559 ·Status: RECRUITING ·Phase: PHASE4
-
Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion
NCT00777140 ·Status: COMPLETED ·Phase: PHASE2
-
Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
NCT06715007 ·Status: RECRUITING
-
To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection
NCT00238667 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients
NCT02907736 ·Status: WITHDRAWN
-
Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke
NCT03062397 ·Status: UNKNOWN ·Phase: PHASE2
-
Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed;
NCT04290494 ·Status: COMPLETED
-
Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke
NCT04491695 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
NCT07139314 ·Status: RECRUITING ·Phase: NA